Mandate

Investor buys out part of Neoventa Medical

July 21, 2006

Investor Growth Capital and CapMan are investing in Neoventa Medical AB, a Swedish medical technology company in the field of fetal monitoring. Investor Growth Capital and CapMan will hold approximately 30% each of the share capital, while the majority of the remaining shares will be owned by SEK Företagsinvest as previous. The new ownership constellation provides the company with SEK 75 million to finance the next phase in Neoventa's growth - focusing on the American market.

Vinge acted as advisor to Neoventa Holding AB. Vinge representatives included Johan Winnerblad, Marcus Axelryd and Theresa Kovac.

Related

Vinge has advised private equity firm Stirling Square Capital Partners

Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023

Vinge advises Stendörren in connection with issuance of green notes and tender offer

Vinge has advised Stendörren Fastigheter AB in connection with its issuance of senior unsecured green notes in an amount of SEK 500 million (within a framework of SEK 600 million) and its parallel tender offer in respect of its previously issued notes due 2024.
September 21, 2023

Vinge has advised Elektroskandia in connection with its majority investment in Aprilice

Vinge has advised Elektroskandia (a Sonepar company) in connection with its acquisition of 70% of the shares in Aprilice, one of the leading solar energy platforms in Northern Europe.
September 20, 2023